Methyl7-Butyl-1,3-diMethyl-2,4-Dioxopyrrolo[2,3-d]Pyrimidine-6-Carboxylate
96%
- Product Code: 213375
CAS:
1086386-32-4
| Molecular Weight: | 293.32 g./mol | Molecular Formula: | C₁₄H₁₉N₃O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
Used in pharmaceutical research as a potent adenosine receptor antagonist, particularly targeting A1 and A2A receptors. Shows promise in developing treatments for neurological disorders such as Parkinson’s disease due to its ability to modulate dopaminergic activity. Also investigated for anti-inflammatory and analgesic properties in preclinical studies. Its structural stability and high binding affinity make it a valuable scaffold in designing new central nervous system agents.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 250mg | 10-20 days | Ft286,921.22 |
+
-
|
Methyl7-Butyl-1,3-diMethyl-2,4-Dioxopyrrolo[2,3-d]Pyrimidine-6-Carboxylate
Used in pharmaceutical research as a potent adenosine receptor antagonist, particularly targeting A1 and A2A receptors. Shows promise in developing treatments for neurological disorders such as Parkinson’s disease due to its ability to modulate dopaminergic activity. Also investigated for anti-inflammatory and analgesic properties in preclinical studies. Its structural stability and high binding affinity make it a valuable scaffold in designing new central nervous system agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :